Abeona Therapeutics (ABEO) Change in Receivables (2011 - 2026)

Abeona Therapeutics' (ABEO) quarterly Change in Receivables came in at $53000.0 in Q1 2026, up 105.3% quarter-over-quarter from -$1.0 million in Q3 2022.

Abeona Therapeutics (ABEO) Change in Receivables (2011 - 2026) Analysis & Trends

Abeona Therapeutics' Change in Receivables history runs 11 years deep, the most recent figure standing at $53000.0 for Q1 2026.

  • On a quarterly basis, Change in Receivables changed N/A year-over-year to $53000.0 in Q1 2026; TTM through Mar 2026 was $53000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $6.1 million, changed N/A from the prior year.
  • Change in Receivables advanced to $53000.0 in Q1 2026 per ABEO's latest filing, from -$1.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $1.0 million in Q2 2022 and bottomed at -$3.0 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 75.30 Mn
4 NuCana 279.75 Bn 279.75 Bn - 2.84 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -39.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Abeona Therapeutics 107.85 Mn -60.42 Mn 6.02 Mn 53,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 53,000.00
Mar 31, 2026 53,000.00
Sep 30, 2022 -1.00 Mn
Sep 30, 2022 -1.00 Mn
Jun 30, 2022 1.00 Mn
Jun 30, 2022 1.00 Mn
Mar 31, 2022 -3.00 Mn
Mar 31, 2022 -3.00 Mn
Dec 31, 2019 -15,000.00
Dec 31, 2019 -15,000.00
Sep 30, 2019 -25,000.00
Sep 30, 2019 -25,000.00
Jun 30, 2019 2,000.00
Jun 30, 2019 2,000.00
Mar 31, 2019 -43,000.00
Mar 31, 2019 -43,000.00
Dec 31, 2018 -271,000.00
Dec 31, 2018 -271,000.00
Sep 30, 2018 305,000.00
Sep 30, 2018 305,000.00